Side-by-side comparison of AI visibility scores, market position, and capabilities
SF YC W20 psychiatric EHR for ketamine/psychedelic/TMS treatment practices; $55.2M total ($40M DFJ/General Catalyst/Tiger Series B May 2022) competing with Valant for emerging mental health treatment specialty EHR.
Osmind is a San Francisco-based psychiatry and mental health EHR (electronic health record) platform — backed by Y Combinator (W20) with $55.2 million in total funding including a $40 million Series B in May 2022 led by DFJ Growth with General Catalyst, Future Ventures, Tiger Global, Susa Ventures, Lachy Groom, and Pear VC — providing psychiatric practices with research-grade EHR technology specialized for emerging mental health treatments including ketamine therapy, psychedelic-assisted psychotherapy (psilocybin, MDMA), transcranial magnetic stimulation (TMS), and electroconvulsive therapy (ECT). Founded in 2020, Osmind captures clinical data during novel psychiatric interventions in structured formats that enable both optimized patient care workflows and real-world evidence research — serving the growing segment of psychiatric practices offering treatment-resistant depression interventions.
Scaleway is a French cloud provider under Iliad Group with ~€150M estimated revenue. Focused on European data sovereignty and GPU cloud for AI. HQ: Paris. Founded 1999.
Scaleway is a French cloud computing provider and subsidiary of Iliad Group, the telecommunications and technology conglomerate founded by billionaire Xavier Niel. Originally launched as Online.net in 1999 and rebranded as Scaleway in 2015, the company has grown into one of Europe's leading independent cloud providers, positioning itself as the European alternative to US hyperscalers for GDPR-sensitive workloads.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.